topotecan

This page covers all topotecan drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting ATP-binding cassette sub-family G member 2.

Targets

ATP-binding cassette sub-family G member 2

Marketed (1)

• Nogitecan · Novartis · Oncology
  Topotecan is a topoisomerase inhibitor that prevents DNA re-ligation, causing double-strand DNA damage.

Patent intelligence

• topotecan patent landscape — aggregated cliff calendar, attackable patents, originator estates